Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02175992
Other study ID # 13/546
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 2012
Est. completion date June 30, 2017

Study information

Verified date May 2022
Source UMC Utrecht
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Pancreatic cancer has a high mortality rate. Patients with an intended curative resection show a median survival of 17-23 months. Therefore, quality of life is very important in this patient group. In this study, the effect of pancreatic surgery on quality of life is measured.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date June 30, 2017
Est. primary completion date December 31, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients with a suspected pancreatic malignancy - eligible for surgery with curative intent - being able to complete questionnaires in Dutch - age >=18 years Exclusion Criteria: - none

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands Department of Surgery, University Medical Center Utrecht Utrecht

Sponsors (1)

Lead Sponsor Collaborator
UMC Utrecht

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Health-related quality of life To assess the influence of pancreatic surgery for patients with a pancreatic malignancy on health-related quality of life 2 years